Literature DB >> 7586652

Vitamin D dependent rickets type II and normal vitamin D receptor cDNA sequence. A cluster in a rural area of Cauca, Colombia, with more than 200 affected children.

A Giraldo1, W Pino, L F García-Ramírez, M Pineda, A Iglesias.   

Abstract

Vitamin D dependent rickets type II is an autosomal recessive disease caused by the vitamin D defective receptor. More than 200 patients with different types of lower limb deformities were detected in a rural area of the Cauca department in the southwest part of Colombia. Patients were well nourished and in good physical condition in spite of their deformities. None of them presented alopecia, myopathy, seizures or aminoaciduria. Serum analysis showed significantly lower serum calcium as compared to normal relatives, though in the normal low range, normal phosphorus, high alkaline phosphatase, normal 25-hydroxyvitamin D3 and high 1,25-dihydroxyvitamin D3, indicating target organ resistance. The cDNA analysis showed normal nucleotide sequence. We suggest that our patients represent a distinct form of receptor-positive resistance to vitamin D. This report is the first extensive study on this class of patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586652     DOI: 10.1111/j.1399-0004.1995.tb04056.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  Genetics and genomic medicine in Colombia.

Authors:  Mauricio De Castro; Carlos Martín Restrepo
Journal:  Mol Genet Genomic Med       Date:  2015-03       Impact factor: 2.183

Review 2.  Genetic Causes of Rickets.

Authors:  Sezer Acar; Korcan Demir; Yufei Shi
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

Review 3.  Diagnosis and Management of Vitamin D Dependent Rickets.

Authors:  Michael A Levine
Journal:  Front Pediatr       Date:  2020-06-12       Impact factor: 3.418

4.  Rickets guidance: part II-management.

Authors:  Dieter Haffner; Maren Leifheit-Nestler; Andrea Grund; Dirk Schnabel
Journal:  Pediatr Nephrol       Date:  2022-03-29       Impact factor: 3.651

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.